Soo-Jin Kim
Technik-/Wissenschafts-/F&E-Leiter bei INOZYME PHARMA, INC.
Vermögen: 2 Mio $ am 30.04.2024
Profil
Soo-Jin Kim is currently the Chief Technical Operations Officer & Senior VP at Inozyme Pharma, Inc. Prior to this, he worked as a Principal Scientist at Bristol Myers Squibb Co., Senior Research & Head-API Development Group at Boehringer Ingelheim Pharmaceuticals, Inc., and Senior Vice President & Head-Bio Plant at Hanmi Pharmaceutical Co., Ltd.
Kim received his undergraduate degree from Cornell University and his graduate and doctorate degrees from the California Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ILSHIN SPINNING CO., LTD
1,31% | 26.04.2023 | 305 460 ( 1,31% ) | 2 Mio $ | 30.04.2024 |
Aktive Positionen von Soo-Jin Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| INOZYME PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.03.2022 |
Ehemalige bekannte Positionen von Soo-Jin Kim
| Unternehmen | Position | Ende |
|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
| HANMI PHARM. CO., LTD. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Soo-Jin Kim
| Cornell University | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| HANMI PHARM. CO., LTD. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
